BCL2 and congenital rubella syndrome: Cit (10 mg/kg) and JSO (50 and 200 mg/kg) administration increased the ratio of Bax/Bcl-2 in CRS mice compared with the control group in the Hip (p < 0.01, p < 0.05, p < 0.01, respectively), and the ratio of Bax/Bcl-2 was notably escalated by JSO (100 and 200 mg/kg) administration in the mPFC region (p < 0.05, p < 0.01, respectively).